j. Submit reports to the hospital organization in charge of the overall quality
assessment program. This includes recommendation for improvement or corrective
actions when needed.
k. Review of areas such as the following:
(1) The proper administration of blood products.
(2) The indications for irradiated blood.
(3) The appropriate use of various blood administration devices such as filters,
blood pumps, and intraoperative autologous transfusion devices.
(4) The monitoring of cell separators for intraoperative recovery and the
collection of plasma or cells from patients undergoing plasmapheresis or cytapheresis
procedures.
Section III. SAFETY
2-8. GENERAL
a. The primary goals of every laboratory safety program are to prevent injury,
disability, and disease transmission and to provide a safe and healthy working
environment. This includes:
(1) Identifying and removing of hazardous conditions or the reducing of the
risks through communication and training and the use of personal protective equipment
(PPE).
(2) Identifying and changing habitual behaviors in individuals who perform
unsafe acts or who are at increased risk for injury.
NOTE: Enforcing good biosafety measures is difficult to accomplish because
risk/dangerous elements (biohazardous material) often cannot be seen.
b. Awareness of biosafety issues has been significantly increased since the
advent of AIDS and its transmission through blood or body fluids.
c. Federal regulatory agencies involved in the safety of health care workers.
(1) Food and Drug Administration (FDA).
(a) Establishes the Code of Federal Regulations (CFR).
MD0868
2-13
Previous Page
